CEO: Sanj K. Patel

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.


Key numbers

Market Capitalization:358924533
Shares Outstanding: 19189000
Float: 15206169.537999999
Next Earning Date:2020-03-05
TTm EPS: -3.3266
TTm Dividend Rate:
200 days moving average:12.95
50 days moving average: 7.41
One day percent Change: 9.18



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,